Will Towana Looney remain dialysis-free one year post-transplant by November 25, 2025?
Yes • 50%
No • 50%
Medical reports and statements from NYU Langone Health
Alabama Woman Receives Third Genetically Modified Pig Kidney Transplant at NYU Langone Health on November 25, 2024, Ends Dialysis
Dec 17, 2024, 04:37 PM
Towana Looney, a 53-year-old woman from Alabama, has become the third person to receive a genetically modified pig kidney transplant. The procedure, which took place at NYU Langone Health on November 25, 2024, marks a significant advancement in xenotransplantation. Looney, who had been on dialysis for eight years due to kidney failure following a pregnancy complication, is recovering well and no longer requires dialysis. This transplant is the latest in efforts to address the chronic shortage of human organs available for transplant, with more than 100,000 people currently on the U.S. transplant list, most needing kidneys. The pig kidney used in Looney's transplant was provided by Revivicor and featured 10 genetic modifications to enhance compatibility with human recipients and reduce the risk of rejection. Looney's successful transplant is seen as a promising step toward future clinical trials, which are expected to begin next year.
View original story
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Severe health issues or transplant failure • 25%
Moderate health with significant complications • 25%
Excellent health with no complications • 25%
Good health with minor complications • 25%
Yes • 50%
No • 50%
Experiencing major complications • 25%
Fully recovered • 25%
Stable with minor issues • 25%
Deceased • 25%
Minor complications managed • 25%
Significant complications • 25%
Fully functional without issues • 25%
Transplant rejection • 25%
Rejection • 25%
Other significant outcome • 25%
Functioning with minor complications • 25%
Functioning without complications • 25%
1-3 • 25%
10 or more • 25%
7-9 • 25%
4-6 • 25%
Infection-related • 25%
Hyperacute rejection • 25%
Acute rejection • 25%
Chronic rejection • 25%